Literature DB >> 23343068

Anemia treatment in patients with chronic kidney disease.

Tilman B Drüeke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23343068     DOI： 10.1056/NEJMe1215043

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Association of Erythropoietin Dose and Route of Administration with Clinical Outcomes for Patients on Hemodialysis in the United States.

Authors:  Daniel G Wright; Elizabeth C Wright; Andrew S Narva; Constance T Noguchi; Paul W Eggers
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-10       Impact factor: 8.237

2.  Association of red blood cell distribution width levels with severity of coronary artery disease in patients with non-ST elevation myocardial infarction.

Authors:  Omer Sahin; Mahmut Akpek; Bahadir Sarli; Ahmet Oguz Baktir; Goktug Savas; Serhat Karadavut; Deniz Elcik; Hayrettin Saglam; Mehmet Gungor Kaya; Huseyin Arinc
Journal:  Med Princ Pract       Date:  2014-12-16       Impact factor: 1.927

Review 3.  Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia.

Authors:  Xiaofan Hu; Jingyuan Xie; Nan Chen
Journal:  Kidney Dis (Basel)       Date:  2020-12-17

4.  RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development.

Authors:  Rakesh Verma; Su Su; Donald J McCrann; Jennifer M Green; Karen Leu; Peter R Young; Peter J Schatz; Jeffrey C Silva; Matthew P Stokes; Don M Wojchowski
Journal:  J Exp Med       Date:  2014-08-04       Impact factor: 14.307

5.  Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.

Authors:  Carlo Barbieri; Elena Bolzoni; Flavio Mari; Isabella Cattinelli; Francesco Bellocchio; José D Martin; Claudia Amato; Andrea Stopper; Emanuele Gatti; Iain C Macdougall; Stefano Stuard; Bernard Canaud
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.